Tomoko Satoh

815 total citations
31 papers, 705 citations indexed

About

Tomoko Satoh is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Tomoko Satoh has authored 31 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Tomoko Satoh's work include Microbial Natural Products and Biosynthesis (3 papers), Bone health and treatments (3 papers) and Vibrio bacteria research studies (2 papers). Tomoko Satoh is often cited by papers focused on Microbial Natural Products and Biosynthesis (3 papers), Bone health and treatments (3 papers) and Vibrio bacteria research studies (2 papers). Tomoko Satoh collaborates with scholars based in Japan, Switzerland and United States. Tomoko Satoh's co-authors include Tsutomu Kamiyama, KAZUO SHIZUME, Kazuteru Yokose, Hiroshi Demura, Kanji Sato, Tomomi Kawasaki, Ayako Okamoto, Toshio Tsushima, Minoru Ozawa and H. Imamura and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Antimicrobial Agents and Chemotherapy and Journal of Bone and Mineral Research.

In The Last Decade

Tomoko Satoh

30 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoko Satoh Japan 14 240 204 100 96 87 31 705
Won Bae Kim South Korea 14 214 0.9× 83 0.4× 72 0.7× 54 0.6× 54 0.6× 42 624
Qiu Li China 17 281 1.2× 241 1.2× 137 1.4× 102 1.1× 28 0.3× 52 898
Kiran Dole United States 13 247 1.0× 79 0.4× 88 0.9× 69 0.7× 50 0.6× 22 532
Michael R. Leadbetter United States 11 280 1.2× 129 0.6× 29 0.3× 88 0.9× 72 0.8× 19 723
P. Scorza Barcellona Italy 14 226 0.9× 223 1.1× 49 0.5× 58 0.6× 126 1.4× 31 758
Michael W. Voice United Kingdom 12 276 1.1× 50 0.2× 211 2.1× 59 0.6× 79 0.9× 21 710
Tomoyoshi Hosokawa Japan 14 318 1.3× 84 0.4× 25 0.3× 50 0.5× 114 1.3× 33 629
Labanyamoy Kole India 16 321 1.3× 55 0.3× 26 0.3× 77 0.8× 48 0.6× 22 688
Nigel B. Rendell United Kingdom 18 432 1.8× 45 0.2× 65 0.7× 97 1.0× 24 0.3× 36 929
G. Towers South Africa 19 347 1.4× 171 0.8× 78 0.8× 15 0.2× 64 0.7× 38 1.0k

Countries citing papers authored by Tomoko Satoh

Since Specialization
Citations

This map shows the geographic impact of Tomoko Satoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Satoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Satoh more than expected).

Fields of papers citing papers by Tomoko Satoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Satoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Satoh. The network helps show where Tomoko Satoh may publish in the future.

Co-authorship network of co-authors of Tomoko Satoh

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Satoh. A scholar is included among the top collaborators of Tomoko Satoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Satoh. Tomoko Satoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohto, Hitoshi, Tsutomu Ishi‐i, Junichi Kitazawa, et al.. (2009). TRANSFUSION COMPLICATIONS: Declining hepatitis C virus (HCV) prevalence in pregnant women: impact of anti‐HCV screening of donated blood. Transfusion. 50(3). 693–700. 7 indexed citations
2.
3.
Satoh, Tomoko, et al.. (2002). . The Journal of The Institute of Image Information and Television Engineers. 56(5). 872–876. 1 indexed citations
4.
Fuchikami, Kinji, Hiroko Togame, Tomoko Satoh, et al.. (2002). A Versatile High-Throughput Screen for Inhibitors of Lipid Kinase Activity: Development of an Immobilized Phospholipid Plate Assay for Phosphoinositide 3-Kinase γ. SLAS DISCOVERY. 7(5). 441–450. 16 indexed citations
5.
Satoh, Tomoko, et al.. (2001). Effects of β-Casomorphins on Neuronal Survival in Culture of Embryonic Chick Dorsal Root Ganglion Neurons. The Japanese Journal of Pharmacology. 86(3). 363–365. 6 indexed citations
6.
Sakaguchi, Minoru, et al.. (1999). Effects of opioids on neuronal survival in culture of embryonic chick dorsal root ganglion neurons. Neuroscience Letters. 262(1). 17–20. 13 indexed citations
7.
Hirata, Takahiro, et al.. (1998). Screening of an Inhibitor of the Tetracycline Efflux Pump in a Tetracycline-Resistant Clinical-Isolate of Staphylococcus aureus 743.. Biological and Pharmaceutical Bulletin. 21(7). 678–681. 15 indexed citations
8.
Kiyohara, Tomoko, Tomoko Satoh, Hiroshi Yamamoto, Atsuko Totsuka, & Yasuo Moritsugu. (1997). THE LATEST SEROEPIDEMIOLOGICAL PATTERN OF HEPATITIS A IN JAPAN. Japanese Journal of Medical Science and Biology. 50(3). 123–131. 22 indexed citations
9.
Kamiyama, Tsutomu, et al.. (1995). Monamidocin, a Novel Fibrinogen Receptor Antagonist. II. Biological Activity and Structure-activity Relationships.. The Journal of Antibiotics. 48(11). 1226–1233. 5 indexed citations
10.
Kamiyama, Tsutomu, et al.. (1995). Sulfobacins A and B, Novel von Willebrand Factor Receptor Antagonists. I. Production, Isolation, Characterization and Biological Activities.. The Journal of Antibiotics. 48(9). 924–928. 39 indexed citations
11.
Satoh, Tomoko, Yüko Yamashita, Tsutomu Kamiyama, & Mikio Arisawa. (1993). Tetrafibricin: A nonpeptidic fibrinogen receptor inhibitor from Streptomyces neyagawaensis. (II) its antiplatelet activities. Thrombosis Research. 72(5). 401–412. 17 indexed citations
12.
Satoh, Tomoko, Yüko Yamashita, Tsutomu Kamiyama, et al.. (1993). Tetrafibricin: A nonpeptidic fibrinogen receptor inhibitor from Streptomyces neyagawaensis (I) its GPIIB/IIIA blockage on solid phase binding assay. Thrombosis Research. 72(5). 389–400. 12 indexed citations
13.
14.
Kamiyama, Tsutomu, et al.. (1993). Tetrafibricin, a novel fibrinogen receptor antagonist. I. Taxonomy, fermentation, isolation, characterization and biological activities.. The Journal of Antibiotics. 46(7). 1039–1046. 30 indexed citations
15.
Kamiyama, Tsutomu, et al.. (1993). Tetrafibricin, a novel fibrinogen receptor antagonist. II. Structural elucidation.. The Journal of Antibiotics. 46(7). 1047–1054. 21 indexed citations
16.
Nakayama, Noboru, Yoshiko Itezono, Tomoko Satoh, et al.. (1992). Ro 09-1679, A NOVEL THROMBIN INHIBITOR.. The Journal of Antibiotics. 45(3). 424–427. 13 indexed citations
17.
Satoh, Tomoko, et al.. (1991). Establishment of Solid Phase GPIIb/IIIa Binding Assay Using Biotinylated Fibrinogen as a Ligand. Japanese Journal of Thrombosis and Hemostasis. 2(4). 323–329. 6 indexed citations
18.
Sato, Kanji, Tomoko Satoh, KAZUO SHIZUME, et al.. (1990). Inhibition of125I Organification and Thyroid Hormone Release by Interleukin-1, Tumor Necrosis Factor-α, and Interferon-γin Human Thyrocytes in Suspension Culture*. The Journal of Clinical Endocrinology & Metabolism. 70(6). 1735–1743. 129 indexed citations
19.
Fujii, Yuko, Kanji Sato, Keizo Kasono, et al.. (1990). Prolonged and ubiquitous inhibition by interferon γ of bone resorption induced by parathyroid hormone-related protein, 1,25-dihydroxyvitamin D3, and interleukin 1 in fetal mouse forearm bones. Calcified Tissue International. 47(3). 178–182. 10 indexed citations
20.
Yamanaka, Hiroyasu, Tomoko Satoh, & Sumió Shinoda. (1987). Preparation of specific antiserum against Vibrio vulnificus hemolysin by immunization with hemolysin-bound liposomes. FEMS Microbiology Letters. 41(3). 313–316. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Won Bae Kim Breakdown of academic impact, for papers by Qiu Li Breakdown of academic impact, for papers by Kiran Dole Breakdown of academic impact, for papers by Michael R. Leadbetter Breakdown of academic impact, for papers by P. Scorza Barcellona Breakdown of academic impact, for papers by Michael W. Voice Breakdown of academic impact, for papers by Tomoyoshi Hosokawa Breakdown of academic impact, for papers by Labanyamoy Kole Breakdown of academic impact, for papers by Nigel B. Rendell Breakdown of academic impact, for papers by G. Towers
Rankless by CCL
2026